Checkpoint Surgical, which has developed an intraoperative nerve stimulation device, is about a third of the way to completing a $3 million series B investment round.

The suburban Cleveland company hopes to close the round by year’s end. Checkpoint would use the funding to boost its sales and marketing staff, more than doubling its employees from seven to 15, and maybe even a few more, CEO Len Cosentino said.
Click for full article